In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape.

The efficacy of drug delivery and other nanomedicine-related therapies largely relies on the ability of nanoparticles to reach the target organ. However, when nanoparticles are injected into the bloodstream, their surface is instantly modified upon interaction with blood components, principally with proteins. It is well known that a dynamic and multi-layered protein structure is formed spontaneously on the nanoparticle upon contact with physiological media, which has been termed protein corona. Although several determinant factors involved in protein corona formation have been identified from in vitro studies, specific relationships between the nanomaterial synthetic identity and its ensuing biological identity under realistic in vivo conditions remain elusive. We present here a detailed study of in vivo protein corona formation after blood circulation of anisotropic gold nanoparticles (nanorods and nanostars). Plasmonic gold nanoparticles of different shapes and sizes were coated with polyethyleneglycol, intravenously administered in CD-1 mice and subsequently recovered. The results from gel electrophoresis and mass spectrometry analysis revealed the formation of complex protein coronas, as early as 10 minutes post-injection. The total amount of protein adsorbed onto the particle surface and the protein corona composition were found to be affected by both the particle size and shape.

[1]  Roberto Cingolani,et al.  Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.

[2]  V. Puntes,et al.  Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona. , 2017, Bioconjugate chemistry.

[3]  Philippe Guyot-Sionnest,et al.  Mechanism of silver(I)-assisted growth of gold nanorods and bipyramids. , 2005, The journal of physical chemistry. B.

[4]  J. Hillier,et al.  A study of the nucleation and growth processes in the synthesis of colloidal gold , 1951 .

[5]  C. Trachsel,et al.  Human Blood Plasma Proteins: Structure and Function , 2008 .

[6]  Tuan Vo-Dinh,et al.  Gold nanostars: surfactant-free synthesis, 3D modelling, and two-photon photoluminescence imaging , 2012, Nanotechnology.

[7]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[8]  Parag Aggarwal,et al.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[9]  Emily R Evans,et al.  Changes in Optical Properties of Plasmonic Nanoparticles in Cellular Environments are Modulated by Nanoparticle PEGylation and Serum Conditions , 2016, Nanoscale Research Letters.

[10]  P. Jain,et al.  Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. , 2006, The journal of physical chemistry. B.

[11]  S. Parasuraman,et al.  Blood sample collection in small laboratory animals , 2010, Journal of pharmacology & pharmacotherapeutics.

[12]  H. Ghandehari,et al.  Differential Protein Adsorption and Cellular Uptake of Silica Nanoparticles Based on Size and Porosity. , 2016, ACS applied materials & interfaces.

[13]  Giulio Caracciolo,et al.  Surface chemistry and serum type both determine the nanoparticle-protein corona. , 2015, Journal of proteomics.

[14]  K. Soo,et al.  Protein Corona around Gold Nanorods as a Drug Carrier for Multimodal Cancer Therapy. , 2017, ACS biomaterials science & engineering.

[15]  Murali M. Yallapu,et al.  Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. , 2015, Biomaterials.

[16]  K. Hamad-Schifferli,et al.  Protein coronas on gold nanorods passivated with amphiphilic ligands affect cytotoxicity and cellular response to penicillin/streptomycin. , 2014, ACS nano.

[17]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[18]  Chad A Mirkin,et al.  Gold nanoparticles for biology and medicine. , 2010, Angewandte Chemie.

[19]  Mostafa A. El-Sayed,et al.  Preparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method , 2003 .

[20]  M. Mahmoudi,et al.  Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.

[21]  Anil K Patri,et al.  Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[22]  Raehyun Kim,et al.  The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum. , 2016, The international journal of biochemistry & cell biology.

[23]  M. El-Sayed,et al.  Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. , 2006, Chemical Society reviews.

[24]  Morteza Mahmoudi,et al.  Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.

[25]  Marilena Hadjidemetriou,et al.  Nanomedicine: Evolution of the nanoparticle corona. , 2017, Nature nanotechnology.

[26]  Katharina Landfester,et al.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.

[27]  W. Kreyling,et al.  Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles , 2013, Nanotechnology.

[28]  S. Stolte,et al.  The nanoparticle biomolecule corona: lessons learned - challenge accepted? , 2015, Chemical Society reviews.

[29]  Alaaldin M. Alkilany,et al.  Protein corona: Opportunities and challenges. , 2016, The international journal of biochemistry & cell biology.

[30]  Vipul Bansal,et al.  Size, shape and surface chemistry of nano-gold dictate its cellular interactions, uptake and toxicity , 2016 .

[31]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[32]  W. Parak,et al.  Gold-Based Nanomaterials for Applications in Nanomedicine. , 2016, Topics in current chemistry.

[33]  L. Liz‐Marzán,et al.  A "Tips and Tricks" Practical Guide to the Synthesis of Gold Nanorods. , 2015, The journal of physical chemistry letters.

[34]  Xiue Jiang,et al.  Impact of shape and pore size of mesoporous silica nanoparticles on serum protein adsorption and RBCs hemolysis. , 2014, ACS applied materials & interfaces.

[35]  Luca Digiacomo,et al.  Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients. , 2016, The international journal of biochemistry & cell biology.

[36]  L. Liz‐Marzán,et al.  Reshaping and LSPR tuning of Au nanostars in the presence of CTAB , 2011 .

[37]  G. Caracciolo,et al.  Influence of dynamic flow environment on nanoparticle-protein corona: From protein patterns to uptake in cancer cells. , 2017, Colloids and surfaces. B, Biointerfaces.

[38]  Dongyu Chen,et al.  Plasma protein adsorption and biological identity of systemically administered nanoparticles. , 2017, Nanomedicine.

[39]  Marilena Hadjidemetriou,et al.  In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. , 2015, ACS nano.

[40]  Darren J. Martin,et al.  Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.

[41]  K. Landfester,et al.  Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. , 2016, Nanoscale.

[42]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[43]  E. Fisher,et al.  The origins and uses of mouse outbred stocks , 2005, Nature Genetics.

[44]  C. Trachsel,et al.  Human Blood Plasma Proteins , 2008 .

[45]  Marilena Hadjidemetriou,et al.  Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles. , 2016, Nanoscale.

[46]  Samir Mitragotri,et al.  A Review of Clinical Translation of Inorganic Nanoparticles , 2015, The AAPS Journal.

[47]  A. De Vizcaya-Ruiz,et al.  A comparison of the human and mouse protein corona profiles of functionalized SiO2 nanocarriers. , 2017, Nanoscale.

[48]  Giulio Caracciolo,et al.  Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.

[49]  Z. Chai,et al.  Protein corona influences liver accumulation and hepatotoxicity of gold nanorods , 2016 .

[50]  S. Muyldermans,et al.  Limiting the protein corona: A successful strategy for in vivo active targeting of anti-HER2 nanobody-functionalized nanostars. , 2017, Biomaterials.

[51]  L. Liz‐Marzán,et al.  Stabilization and Encapsulation of Gold Nanostars Mediated by Dithiols. , 2015, Small.